An Immunotherapy Renaissance in Hepatobiliary Cancers

An Immunotherapy Renaissance in Hepatobiliary Cancers - YouTube

Immunotherapy has revolutionized the way we treat many malignancies, including hepatobiliary cancers. In this Grand Rounds, UCSF oncologists ...

Department of Medicine Grand Rounds: An Immunotherapy ...

An Immunotherapy Renaissance in Hepatobiliary Cancers Session moderated by Bob Wachter Immunotherapy has revolutionized the way we treat many malignancies, ...

Emerging immunotherapy for HCC: A guide for hepatologists

Immuno-oncology has been paradigm shifting for the treatment of human cancers, with strong and durable antitumor activity in a subset of patients across a ...

Immunotherapy for hepatocellular carcinoma: A promising ...

Accordingly, liver resection is considered the first-line treatment for HCC in patients with compensated cirrhosis[8]. Thermal ablation is ...

Immunotherapy for hepatobiliary cancers: Emerging targets and ...

In this review, we will provide an overview of the current emerging targets for liver cancer immunotherapy, with particular emphasis on GPC3 and MSLN. We will ...

Immunotherapy in liver cancer: overcoming the tolerogenic liver ...

Immunotherapy has emerged as a promising avenue for cancer treatment, leveraging the body's immune system to target and destroy cancer cells. However, its ...

Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer

Over the last decade, immunotherapy has significantly improved the therapeutic landscape of solid tumors. There is an increasing number of ...

Hepatobiliary cancers and immunotherapy: where are we now and ...

Currently, only two ICIs are approved for use in hepatobiliary cancers: nivolumab and pembrolizumab. First, pembrolizumab was approved for either microsatellite ...

Combining Liver-Directed and Immunotherapy in Advanced ...

Hepatocellular carcinoma (HCC) is a highly morbid tumor with diverse genomic heterogeneity that poses a major therapeutic barrier.

Immunotherapy for Liver Cancer | Moffitt

Cancer immunotherapies work by stimulating the body's immune system and strengthening its natural response to tumor cells.

How Immunotherapy Is Making an Impact in Liver Cancer

Immunotherapy treatments that unleash the immune system's ability to fight cancer offer a promising new avenue through which doctors can potentially improve ...

The State of Immunotherapy in Hepatobiliary Cancers - MDPI

Immunotherapy represents a promising approach to improve outcomes, but the immunosuppressive tumor microenvironment of the liver characteristic of hepatobiliary ...

Biomarker May Predict Immunotherapy Response in Liver Cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy ...

Expanding Immunotherapy Options for Liver Cancer Patients

The FDA expanded the use of the immunotherapy pembrolizumab to include the treatment of certain patients with liver cancer.

Advances in immunotherapy for hepatocellular carcinoma - Nature

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated by the immune system. Systemic therapy is used in ...

Immunotherapy for Liver Cancer - American Cancer Society

Immunotherapy helps boost the body's immune system to destroy liver cancer cells more effectively. Learn more here.

Society for Immunotherapy of Cancer (SITC) clinical practice ...

Because HCC usually develops against a background of cirrhosis, immunotherapy for liver tumors is complex and oncologists need to account for both immunological ...

Immunotherapy for liver cancer

Immunotherapy helps to strengthen or restore the immune system's ability to fight cancer. This works to kill cancer cells and stop cancer cells from growing ...

Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and ...

Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind ...

Immunotherapy for Liver Cancer - Cancer Research Institute

Immunotherapy for liver cancer can enhance cancer-fighting immune system responses, but may not always be available or viable for patients with a history of ...